Industrials [ 3/12 ] | Trading Companies & Distributors [ 42/74 ]
NYSE MKT | Common Stock
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia.
The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's.
Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease.
In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers.
The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023.
IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 18, 26 | -0.02 Increased by 0.00% | -0.02 |
| Nov 17, 25 | -0.02 Increased by 0.00% | -0.02 |
| Aug 5, 25 | -0.01 Increased by +50.67% | -0.03 Increased by +50.67% |
| Jun 30, 25 | -0.02 Increased by +95.00% | -0.02 |
| Feb 12, 25 | -0.02 Increased by +77.78% | -0.03 Increased by +33.33% |
| Nov 7, 24 | -0.02 Increased by +60.00% | -0.03 Increased by +33.33% |
| Aug 7, 24 | -0.03 Increased by +25.00% | -0.03 |
| Jun 24, 24 | -0.40 Decreased by -427.01% | -0.04 Decreased by -900.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 317.00 K Decreased by -3.94% | -2.40 M Decreased by -100.67% | Decreased by -757.73% Decreased by -108.90% |
| Dec 31, 25 | 350.00 K Increased by +36.19% | -726.00 K Increased by +60.31% | Decreased by -207.43% Increased by +70.85% |
| Sep 30, 25 | 191.00 K Decreased by -53.64% | -1.82 M Decreased by -6.06% | Decreased by -953.40% Decreased by -128.77% |
| Jun 30, 25 | 328.00 K Increased by +20.59% | -1.60 M Increased by +32.76% | Decreased by -487.50% Increased by +44.24% |
| Mar 31, 25 | 330.00 K Increased by +11.86% | -1.20 M Increased by +58.51% | Decreased by -362.73% Increased by +62.91% |
| Dec 31, 24 | 257.00 K Increased by +25.98% | -1.83 M Increased by +67.28% | Decreased by -711.67% Increased by +74.02% |
| Sep 30, 24 | 412.00 K Increased by +41.58% | -1.72 M Increased by +29.95% | Decreased by -416.75% Increased by +50.52% |
| Jun 30, 24 | 272.00 K Decreased by -50.99% | -2.38 M Decreased by -14.60% | Decreased by -874.26% Decreased by -133.84% |